Stay updated on JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial
Sign up to get notified when there's something new on the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page.

Latest updates to the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedFooter area updated: added Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; this appears to be a UI/maintenance update and does not modify study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedThe notice about government funding and operating status was removed from the page. The core trial information (title, design, eligibility criteria, endpoints) remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check70 days agoChange DetectedThe screenshots show cosmetic layout and style updates to the study details page without changes to core content like the title, conditions, or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check91 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference5%

- Check98 days agoChange DetectedThe page now shows Revision: v3.1.0 replacing the old Revision: v3.0.2. This reflects an update to the software/version information on the page.SummaryDifference0.1%

Stay in the know with updates to JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page.